Single-cell RNA sequencing (scRNA-seq) analysis conducted on TdLN tissues from NSCLC patients has revealed the presence of TTSM cells and proved this subgroup as bona fide responders to PD-1/PD-L1 blockade treatment in TdLNs 16-17. Here, CD274 is linked to non-small cell lung carcinoma.